Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients

M. Deuschle; I. Heuser; K. Lieb

doi:10.1055/s-2003-825304

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000054.xml

Share / Bookmark

Facebook X Linkedin Weibo

Pharmacopsychiatry 2003; 36 - 53
DOI: 10.1055/s-2003-825304

Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients

M Deuschle ¹, I Heuser ¹, K Lieb ²

¹Central Institute of Mental Health, Mannheim, Germany
²Dept. of Psychiatry and Psychotherapy, University of Freiburg, Germany

Congress Abstract

Substance P (SP) is considered to be involved in the pathophysiology of depression. In 80 depressed patients, we measured serum SP after washout of pre-treatment, after 2 and 4 weeks of treatment with amitriptyline and paroxetine. Additionally, SP was measured in the cerebrospinal fluid of 12 patients before and after treatment. Independent of clinical response and medication, SP serum concentrations did not change during treatment. Serum and CSF SP concentrations were not related and CSF concentrations of SP did not change during treatment. Our data indicate that SP in serum may not validly reflect CNS expression of the peptide and that SP concentrations show no major changes due to antidepressant treatment.